A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia

Type of Cancer
Leukemia

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.